Do you want to advance your innovation? Apply for the Heidelberg Innovation Prize and gain access to lab space and equipment at the world-class incubator at BioLabs. Register by February 7th ...
Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...
Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...
Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...
Boehringer Ingelheim's attempt to develop the first ... of two mental health programmes singled out by Boehringer's head of innovation, Dr Paola Casarosa, at an R&D update last year as having ...
Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) with Hyderabad-based EMRI Green Health Services a GVK enterprise, the operator of the Government-funded 108 National Emergency ...
Besides opnMe, Koester established scientific crowdsourcing as a new open innovation tool to attract externally generated new therapeutic concepts for Boehringer Ingelheim’s pre-clinical pipeline.
The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like ...
The E Ink Innovation Prize will award up to $300,000 over the next three years to teams helping solve the world’s most pressing issues. “This partnership with MIT Solve underscores our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results